|
HY-144088-5mg
|
MedChemexpress LLC
|
ZYF0033 [CAS 2380300-79-6]
|
|
COVID-19-immunoregulation
|
|
|
HY-144088-50mg
|
MedChemexpress LLC
|
ZYF0033 [CAS 2380300-79-6]
|
|
COVID-19-immunoregulation
|
|
|
HY-W250113-100mg
|
MedChemexpress LLC
|
Zymosan A [CAS 58856-93-2]
|
|
|
|
|
HY-W250113-50mg
|
MedChemexpress LLC
|
Zymosan A [CAS 58856-93-2]
|
|
|
|
|
HY-P1009-1mg
|
MedChemexpress LLC
|
Z-YVAD-FMK [CAS 210344-97-1]
|
|
Cancer-programmed cell death
|
|
|
HY-P1009-10mg
|
MedChemexpress LLC
|
Z-YVAD-FMK [CAS 210344-97-1]
|
|
Cancer-programmed cell death
|
|
|
HY-P1009-5mg
|
MedChemexpress LLC
|
Z-YVAD-FMK [CAS 210344-97-1]
|
|
Cancer-programmed cell death
|
|
|
HY-P1009-1mL
|
MedChemexpress LLC
|
Z-YVAD-FMK [CAS 210344-97-1] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-P71673-10ug
|
MedChemexpress LLC
|
ZYX, Human (HEK293, His)
|
|
|
|
|
HY-P71673-5ug
|
MedChemexpress LLC
|
ZYX, Human (HEK293, His)
|
|
|
|
|
HY-P71673-50ug
|
MedChemexpress LLC
|
ZYX, Human (HEK293, His)
|
|
|
|
|
HY-100472-10mg
|
MedChemexpress LLC
|
ZYZ-488 [CAS 1470302-79-4]
|
|
Cancer-programmed cell death
|
|
|
HY-100472-100mg
|
MedChemexpress LLC
|
ZYZ-488 [CAS 1470302-79-4]
|
|
Cancer-programmed cell death
|
|
|
HY-100472-5mg
|
MedChemexpress LLC
|
ZYZ-488 [CAS 1470302-79-4]
|
|
Cancer-programmed cell death
|
|
|
HY-100472-50mg
|
MedChemexpress LLC
|
ZYZ-488 [CAS 1470302-79-4]
|
|
Cancer-programmed cell death
|
|
|
HY-100472-1mL
|
MedChemexpress LLC
|
ZYZ-488 [CAS 1470302-79-4] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-148417-10mg
|
MedChemexpress LLC
|
ZZL-7 [CAS 99141-91-0]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-148417-100mg
|
MedChemexpress LLC
|
ZZL-7 [CAS 99141-91-0]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-148417-25mg
|
MedChemexpress LLC
|
ZZL-7 [CAS 99141-91-0]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-148417-5mg
|
MedChemexpress LLC
|
ZZL-7 [CAS 99141-91-0]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-148417-50mg
|
MedChemexpress LLC
|
ZZL-7 [CAS 99141-91-0]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-111838A-10mg
|
MedChemexpress LLC
|
ZZW-115 (hydrochloride) [CAS 10122-45-9]
|
|
Cancer-programmed cell death
|
|
|
HY-111838A-100mg
|
MedChemexpress LLC
|
ZZW-115 (hydrochloride) [CAS 10122-45-9]
|
|
Cancer-programmed cell death
|
|
|
HY-111838A-25mg
|
MedChemexpress LLC
|
ZZW-115 (hydrochloride) [CAS 10122-45-9]
|
|
Cancer-programmed cell death
|
|
|
HY-111838A-5mg
|
MedChemexpress LLC
|
ZZW-115 (hydrochloride) [CAS 10122-45-9]
|
|
Cancer-programmed cell death
|
|
